Insider Trading History of Bios Equity Partners Ii, Lp

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Bios Equity Partners Ii, Lp since 2023. This trader's CIK number is 1813313. At the time of last reporting, Bios Equity Partners Ii, Lp was the Officer of Actuate Therapeutics, Inc.. (stock ticker symbol ACTU). Also see all insider trading activities at Actuate Therapeutics, Inc..

Note that in the past Bios Equity Partners II, LP also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Actuate Therapeutics, Inc. (ACTU) by Bios Equity Partners Ii, Lp

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 ACTU 71,428 $499,996 0 $0 0 $0
2024 ACTU 500,000 $4,000,000 24,999 $224,991 0 $0

Yearly summary of insider trading at Azitra, Inc. (AZTR) by Bios Equity Partners Ii, Lp

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 AZTR 2,297,490 $5,743,725 669,317 $0 0 $0


Insider trading activities at 2 companies by Bios Equity Partners Ii, Lp:

1. Actuate Therapeutics, Inc. (ACTU)

2. Azitra, Inc. (AZTR)

Table 1. Insider trading of Actuate Therapeutics, Inc. (ACTU) by Bios Equity Partners Ii, Lp

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-06-27 ACTU Buy 71,428 7.00 499,996
2024-08-14 ACTU Sale 24,999 9.00 224,991
2024-08-14 ACTU Buy 500,000 8.00 4,000,000

Table 2. Insider trading of Azitra, Inc. (AZTR) by Bios Equity Partners Ii, Lp

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-06-21 AZTR Sale 669,317 .00 0
2023-06-21 AZTR Buy 2,297,490 2.50 5,743,725

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bios Equity Partners Ii, Lp (Officer of Actuate Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.